Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Reducing Risk of Type 2 Diabetes: Hydroxychloroquine Use in Pre-Diabetes

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Frederico Toledo, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01326533
First received: March 29, 2011
Last updated: March 25, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: August 2013
  Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)